Keyphrases
Bradykinin
100%
C1 Inhibitor
100%
Bradykinin B2 Receptor
100%
Icatibant
100%
Endothelial Nitric Oxide Synthase (eNOS)
63%
Receptor-interacting Protein Kinase 1 (RIPK1)
45%
Protein Expression
45%
C57BL
27%
Nitroarginine
27%
Angioedema
27%
NO Donors
27%
MRNA Expression
18%
Intracellular Calcium
18%
Pentaerythritol Tetranitrate
18%
Protein Level
9%
Overexpression
9%
Lung
9%
Littermate
9%
Endothelial Cells
9%
ACE Inhibitors
9%
Porcine
9%
Diclofenac
9%
Cyclooxygenase-1 (COX-1)
9%
Induced Activation
9%
Receptor Antagonist
9%
Concentration-dependent
9%
NOS Inhibitors
9%
Plasma Pool
9%
Receptor Expression
9%
Hereditary Angioedema
9%
Constriction
9%
Receptor Activity
9%
Functional Importance
9%
Brain Endothelial Cells
9%
Aortic Rings
9%
INIS
receptors
100%
stability
100%
bradykinin
100%
indium hydrides
100%
mice
30%
proteins
30%
messenger-rna
10%
calcium
10%
pentaerythritol tetranitrate
10%
reactivity
5%
data
5%
levels
5%
skin
5%
lungs
5%
comparative evaluations
5%
variations
5%
brain
5%
concentration
5%
pools
5%
plasma
5%
rings
5%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Isoniazid
100%
Icatibant
100%
Bradykinin
100%
Receptor Protein
25%
Angioneurotic Edema
20%
C57BL 6 Mouse
15%
N(g) Nitroarginine
15%
Messenger RNA
10%
Pentaerythrityl Tetranitrate
10%
Nitric Oxide Synthase
5%
Murine
5%
Dipeptidyl Carboxypeptidase Inhibitor
5%
Receptor Antagonist
5%
Prostaglandin Synthase
5%
Extravasation
5%
Diclofenac
5%
Immunology and Microbiology